Boehringer Ingelheim Pharmaceuticals recently announced that adding its soft mist inhaler device Spiriva Respimat to deliver asthma maintenance drugs helps patients with allergic asthma better control their symptoms. The findings were presented at the 2016 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, held March 4-7 in Los Angeles, California. Asthma is a chronic condition that affects … Continue reading Allergic Asthma Patients Show Improvement by Adding Spiriva Respimat to Therapy, According to New Analyses of Data